Press Release
December 28, 2017

BYLINE: The 2018 Biosimilar Litigation Landscape: A Primer (BioPharma Dive)

Associate Alison Siedor discuss recent activity around the 2010 Biologics Price Competition and Innovation Act (BPCIA) and how it set up an abbreviated biosimilar regulatory pathway and a unique litigation framework for resolving related patent disputes.

Read the full article.